Sinco Pharmaceuticals Holdings Ltd. Financial Overview
Sinco Pharmaceuticals Holdings Ltd.'s market cap is currently HK$361.85M. The company's EPS TTM is HK$0.013; its P/E ratio is 7.88; and it has a dividend yield of 1.12%. Sinco Pharmaceuticals Holdings Ltd. is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
